From the Clinical Proteomic Tumor Analysis Consortium (CPTAC) database, we observed that the lung cancer tumor tissues exhibited a significantly higher level of SMC4 protein than that in the normal tissues (p < 0.001) (Figure 6C). This evidence concerns the gene SMC4 and lung carcinoma.